Wegovy vs Mounjaro: The Complete Treatment Comparison
Wegovy or Mounjaro or Ozempic: Understanding Your Treatment Options
When searching for "wegovy or mounjaro or ozempic", you're comparing three distinct treatments with important differences. Wegovy contains semaglutide and works as a GLP-1 receptor agonist, whilst Mounjaro contains tirzepatide and functions as a dual GIP and GLP-1 receptor agonist, targeting two hormone pathways simultaneously. Ozempic, though containing the same semaglutide as Wegovy, is licensed exclusively for type 2 diabetes management in the UK, making it unsuitable for weight management purposes. This leaves Wegovy and Mounjaro as your two evidence-based options for weight management, both available as prescription-only medicines through our GPhC-registered pharmacy.
The choice between Wegovy or Mounjaro depends on several factors including your medical history, treatment goals, and practical considerations like storage requirements. Both treatments require dose escalation over several months, but they follow different schedules and reach different maintenance doses. Understanding these differences helps you make an informed decision with your prescriber's guidance, ensuring you select the treatment most likely to support your long-term weight management success alongside a reduced-calorie diet and increased physical activity.
Wegovy or Mounjaro Pricing: Transparent Costs for Both Options
When comparing wegovy or mounjaro or ozempic costs, transparency matters for your financial planning. Wegovy pricing starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and reaching the 2.4mg maintenance dose at £209.99 per pen. Our bundle options provide convenience for your treatment journey, such as the Intro Duo containing both starter doses (0.25mg and 0.5mg) for £169.99, ensuring seamless progression without multiple orders. New customers apply code FIRST40 at checkout, whilst returning customers use code DOSE25 to access these competitive prices.
Mounjaro follows its own pricing structure with six available doses from 2.5mg to 15mg, each designed for the dual hormone mechanism that distinguishes it from Wegovy's single GLP-1 approach. Both treatments represent significant monthly investments, but the value lies in their clinical evidence and the comprehensive support provided through our regulated pharmacy service. Your prescriber will help determine which option offers the best value for your specific circumstances, considering both the financial commitment and the treatment's suitability for your weight management goals.
Clinical Evidence: Wegovy or Mounjaro or Ozempic Research Foundations
The STEP clinical trial programme provides robust evidence for Wegovy's effectiveness, with STEP 1 demonstrating that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial further showed a 20% reduction in major cardiovascular events, highlighting benefits beyond weight management. These results established Wegovy as an evidence-based prescription-only medicine for weight management when combined with lifestyle interventions.
Mounjaro's clinical evidence stems from the SURMOUNT trial series, demonstrating the effectiveness of tirzepatide's dual hormone approach in weight management settings. When considering wegovy or mounjaro or ozempic research, it's important to note that direct head-to-head comparisons aren't available due to different trial designs and patient populations. Both treatments show substantial efficacy in their respective clinical programmes, providing you with two scientifically-validated options supported by rigorous regulatory approval processes.
How Wegovy Works in Your Body
Wegovy functions as a GLP-1 receptor agonist, mimicking a natural hormone your intestines produce after eating called glucagon-like peptide-1. This mechanism works primarily in your brain's appetite centres, reducing hunger signals and promoting feelings of fullness after smaller meals than you might typically consume. The treatment may also slow gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety throughout the day. Unlike rapid-acting appetite suppressants, Wegovy works gradually to reset your body's appetite regulation systems over time. This biological approach explains why the treatment requires several months of dose escalation to reach full effectiveness, allowing your body to adapt to the medication's appetite-modifying effects whilst minimising potential side effects.
EverydayMeds Ordering Process for Wegovy or Mounjaro
Our streamlined process begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals to determine suitability for either Wegovy or Mounjaro. Once submitted, your assessment undergoes review by our qualified prescribers within 3 working days (or 24 hours with our express service), ensuring thorough evaluation of your individual circumstances. Upon approval, your chosen treatment ships via next-day delivery using cold-chain temperature-controlled packaging to maintain medication integrity from our GPhC-registered pharmacy (#9012878) directly to your address. We provide detailed injection instructions, dose escalation guidance, and ongoing support throughout your treatment journey. This regulated process ensures you receive genuine medication with proper medical oversight, distinguishing our service from unregulated online retailers that may compromise your safety.
Storage and Practical Considerations: Wegovy or Mounjaro Differences
Storage requirements represent a key practical difference when choosing between wegovy or mounjaro or ozempic options, particularly for frequent travellers or those with busy lifestyles. Wegovy offers superior storage flexibility, remaining stable for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both treatments require initial refrigerated storage at 2-8°C and come in pre-filled FlexTouch pens for convenient once-weekly injection. The dose escalation schedules differ significantly: Wegovy progresses through five doses over 16 weeks before reaching maintenance, whilst Mounjaro follows a six-dose escalation potentially extending to higher maximum doses. Understanding these practical aspects helps you choose the treatment that best fits your lifestyle while maintaining the consistent weekly dosing schedule essential for optimal results. Your prescriber will provide specific guidance on injection technique, site rotation, and storage management to maximise treatment effectiveness.
Wegovy or Mounjaro: Mechanism Differences That Matter
The fundamental distinction between these treatments lies in their hormonal targets: Wegovy activates only GLP-1 receptors, whilst Mounjaro activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors simultaneously. This dual action may provide different metabolic effects, though both treatments ultimately work to reduce appetite and support weight management when combined with lifestyle changes. Some patients may respond better to single-pathway activation, whilst others might benefit from the dual-hormone approach, highlighting why having both options available matters for personalised treatment.
Your prescriber considers various factors when recommending between wegovy or mounjaro or ozempic alternatives, including your medical history, previous treatment responses, and individual risk factors. Neither treatment is inherently superior; rather, they offer different approaches to the same goal of supporting sustainable weight management. This is why EverydayMeds stocks both options, ensuring your prescriber can select the most appropriate treatment for your specific circumstances without being limited by pharmacy inventory constraints.
Ready to Choose Between Wegovy or Mounjaro? Start Your Assessment
Both Wegovy and Mounjaro are available through EverydayMeds with the same high-quality service standards, cold-chain delivery, and ongoing clinical support regardless of which treatment your prescriber recommends. New customers can apply code FIRST40 at checkout, whilst returning customers use DOSE25 to access competitive pricing on either treatment option. Our clinical assessment takes just 3 minutes to complete and covers all necessary medical information for your prescriber to make an informed recommendation between these two effective weight management treatments. Don't let indecision delay your weight management journey when expert guidance is available to help you choose the right option. Visit our weight loss collection to begin your clinical assessment today, knowing that whichever treatment is recommended, you'll receive the same exceptional service and genuine medication from our regulated UK pharmacy. Start your assessment now and take the first step towards evidence-based weight management support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
